IL1B and myocardial infarction: Therefore, interventions that inhibit NETosis, S100A8/A9, and IL‐1β during the acute inflammatory phase after myocardial infarction may exert beneficial effects on the post‐infarction inflammatory process and ventricular remodelling.15